SCOTUS Turns Down More False Claims Act Whistleblower Cases

Updated Story: An earlier version of this story inadvertently referred to the cases as Fair Claims instead of False Claims cases. The Supreme Court has declined a second opportunity in its current term to consider cases about whistleblower allegations of health care False Claims Act violations, following a brief from the Solicitor General stating that the issue of how to handle claims of fraud under the act is settled and the case should not proceed. In the...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 10/20/2022
CMS Volume: 
Vol. 25, No. 42
Author: 

Lobbyists Expect Some Resistance To Telehealth Policies At State Level

As lobbyists push for a federal extension of pandemic telehealth waivers before year’s end, stakeholders also are lobbying for policies at the state level that would promote telehealth usage even if federal COVID-19 public health emergency telehealth waivers expire after the 151-day extension. Although lobbyists say that the telehealth movement at the state level has been widely successful during the pandemic, they anticipate some states may want to walk back telehealth policies over fears of fraud and over-utilization and as...
Article Type: 
Site Name: 
InsideHealthPolicy.com
HEA Issue: 
Health Exchange Alert Weekly Report - 10/26/2022
HEA Volume: 
Vol. 10, No. 43
Author: 

Lobbyists Expect Some Resistance To Telehealth Policies At State Level

As lobbyists push for a federal extension of pandemic telehealth waivers before year’s end, stakeholders also are lobbying for policies at the state level that would promote telehealth usage even if federal COVID-19 public health emergency telehealth waivers expire after the 151-day extension. Although lobbyists say that the telehealth movement at the state level has been widely successful during the pandemic, they anticipate some states may want to walk back telehealth policies over fears of fraud and over-utilization and as...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

FDA For The First Time Seeks Injunction Against E-Cigarette Makers

FDA and the Justice Department have asked federal district courts to step in and force six e-cigarette companies to stop manufacturing, selling and distributing their e-cigarettes, marking the first time FDA has initiated court action to enforce the Food, Drug and Cosmetic Act’s premarket review requirements for new tobacco products, the agency announced Tuesday (Oct. 18). Lawmakers and public health and anti-tobacco organizations have repeatedly urged the agency to remove illegal e-cigarette products from the market and ban flavored e-cigarettes...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/21/2022
FDA Volume: 
Vol. 28, No. 42
Author: 


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.